List of insiders holdings for GLYCOMIMETICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 2024-01-29 16:31:11 | 9,544,262 0 | 9,544,262 | Form 13G |
| BARRIS PETER J 10% Owner | 2018-05-11 17:01:54 | 0 9,089,041 | 9,089,041 | Form 4 |
| Invus Public Equities L.P. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Wittouck Amaury Stichting Administratiekantoor Westend Invus Public Equities Advisors LLC 10% Owner | 2024-02-09 17:03:53 | 8,589,064 0 | 8,589,064 | Form 13G |
| NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd BASKETT FOREST DRANT RYAN D KERINS PATRICK J KOLLURI KRISHNA KITTU MOTT DAVID M Viswanathan Ravi Weller Harry R 10% Owner | 2014-01-15 17:14:28 | 4,093,377 0 | 4,093,377 | Form 4 |
| NEW ENTERPRISE ASSOCIATES 10 L P NEA PARTNERS 10 L P 10% Owner | 2024-02-29 19:28:30 | 4,007,977 0 | 4,007,977 | Form 13D |
| Sanofi 10% Owner | 2013-11-07 15:29:17 | 0 2,387,250 | 2,387,250 | Form 3 |
| SANDELL SCOTT D 10% Owner | 2023-01-27 17:15:50 | 0 2,237,196 | 2,237,196 | Form 4 |
| Semerjian Harout Chief Executive Officer | 2024-01-17 16:05:25 | 695,000 0 | 695,000 | Form 4 |
| King Rachel K. Director | 2024-04-02 16:05:29 | 515,194 143,901 | 659,095 | Form 4 |
| Gust William M. Director | 2014-01-15 16:58:23 | 0 409,947 | 409,947 | Form 4 |
| Magnani John L. SVP of Research, CSO | 2022-11-14 16:11:48 | 366,078 4845 | 370,923 | Form 4 |
| Thackray Helen M. SVP Clinical Development, CMO | 2021-01-22 16:05:00 | 252,115 0 | 252,115 | Form 4 |
| Johnson Bruce S SVP & Chief Commercial Officer | 2024-01-17 16:05:28 | 250,000 0 | 250,000 | Form 4 |
| Rock Edwin Chief Medical Officer | 2024-01-17 16:05:20 | 250,000 0 | 250,000 | Form 4 |
| Rath Chinmaya SVP and Chief Business Officer | 2024-01-17 16:05:15 | 250,000 0 | 250,000 | Form 4 |
| Hahn Brian M. SVP Finance, CFO | 2024-01-17 16:05:12 | 250,000 0 | 250,000 | Form 4 |
| Feldman Eric Jay Chief Medical Officer | 2021-03-08 16:14:39 | 210,498 0 | 210,498 | Form 3 |
| JUNIUS DANIEL M Director | 2024-04-02 16:05:38 | 98,459 0 | 98,459 | Form 4 |
| Andrews Patricia S Director | 2024-01-02 16:05:26 | 58,608 0 | 58,608 | Form 4 |
| Koenig Scott Director | 2023-06-02 16:10:27 | 36,750 0 | 36,750 | Form 4 |
| Goldberg Mark Alan Director | 2024-04-02 16:05:22 | 24,828 11,497 | 36,325 | Form 4 |
| PEARSON TIMOTHY R Director | 2023-05-22 16:21:48 | 35,000 0 | 35,000 | Form 4 |
| Jackson Scott Thomas Director | 2023-05-22 16:18:57 | 35,000 0 | 35,000 | Form 4 |
| Girard Armand SVP, Chief Business Officer | 2022-11-14 16:04:18 | 29,161 0 | 29,161 | Form 4 |
| TOP FRANKLIN H JR Director | 2016-05-19 16:14:09 | 11,000 0 | 11,000 | Form 4 |
| BARRETT M JAMES Director 10% Owner | 2018-05-21 16:26:52 | 11,000 0 | 11,000 | Form 4 |
| HENOS MICHAEL A Director | 2015-08-11 16:47:00 | 11,000 0 | 11,000 | Form 4 |
| Baldwin John J. Director | 2016-07-01 11:43:16 | 1210 0 | 1210 | Form 4 |